IL17A and Alzheimer disease: In acute AD lesions, Th17-derived cytokines such as IL-17 and IL-22 are markedly elevated (Simon et al., 2014), which aggravates skin inflammation and disrupts epidermal barrier integrity (Asarch et al., 2008; Korn et al., 2009).